One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1136/jitc-2021-002535
Copy DOI Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: May 1, 2021 |
 Citations: 12 |  License type: open-access |
Affiliation: Harvard University, Dana-Farber Cancer Institute, Moffitt Cancer Center, University of Wisconsin–Madison, Northwestern University, Yale University, Massachusetts General Hospital, Angeles Clinic and Research Institute, University of Arkansas for Medical Sciences, National Cancer Institute, University of North Carolina at Chapel Hill, UPMC Hillman Cancer Center, California Pacific Medical Center, The Ohio State University, Wayne State University, Karmanos Cancer Institute, Greater Baltimore Medical Center, Case Western Reserve UniversityBackgroundThe impact of immune-related adverse events (irAEs) occurring from adjuvant use of immunotherapy and of their management on relapse-free survival (RFS) and overall survival (OS) outcomes is currently not well...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
